François Lemonnier

10PUBLICATIONS
118CO-AUTHORS
Models of care and place of birthTumour immunologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 21, 2026
Contemporary Treatment and Survival Outcomes in Mantle Cell Lymphoma: A National Real-World Analysis From REALYSA, a LYSA Cohort.

|Oct 07, 2025
Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma.

David Vallois, Edoardo Missiaglia, Luis Veloza

|May 20, 2025
Induction of p53-mediated apoptosis by azacitidine in patient-derived xenograft follicular helper T-cell lymphoma model.

Gamze Tari Crochet, Selcen Ari-Yuka, Anja Fischer

|May 01, 2025
TRANSCAR: real-world outcomes of CD19 CAR T-cell therapy in relapsed/refractory transformed indolent lymphomas.

Pierre Stephan, Roberta Di Blasi, Louise Roulin

|Apr 24, 2025
Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study.

Clémentine Sarkozy, Loïc Chartier, Vincent Ribrag

|Aug 20, 2024
Outcome of patients with large B-cell lymphoma treated with tafasitamab plus lenalidomide either before or after CAR T-cell therapy.

Vincent Camus, Roch Houot, Gabriel Brisou

Pageof 2

Frequent Collaborators

4 joint publications

Olivier Tournilhac

4 joint publications

Ghandi Damaj

3 joint publications

Roch Houot

3 joint publications

Lucie Oberic